Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the field of biopharmaceuticals, providing promising improvements throughout numerous health care and industrial applications. With its structural similarity to Obviously derived human serum albumin, OsrHSA supplies a safer, much more reliable choice for therapeutic use,